CD274 and cancer: A thorough understanding of the regulatory mechanism of PD-L1 will help us to make a comprehensive evaluation of immune-targeting therapy, further enhance the therapeutic effect, and expand the scope of its use by selecting targeted patients and combination use with other anticancer drugs as well as breaking the limitation of cancer tolerance to immunotherapy.